BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24370841)

  • 1. Review of bilayer tablet technology.
    Abebe A; Akseli I; Sprockel O; Kottala N; Cuitiño AM
    Int J Pharm; 2014 Jan; 461(1-2):549-58. PubMed ID: 24370841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interfacial bonding in formulated bilayer tablets.
    Chang SY; Sun CC
    Eur J Pharm Biopharm; 2020 Feb; 147():69-75. PubMed ID: 31870828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axial strength test for round flat faced versus capsule shaped bilayer tablets.
    Franck J; Abebe A; Keluskar R; Martin K; Majumdar A; Kottala N; Stamato H
    Pharm Dev Technol; 2015 Mar; 20(2):139-45. PubMed ID: 24219774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical factors in manufacturing multi-layer tablets--assessing material attributes, in-process controls, manufacturing process and product performance.
    Vaithiyalingam SR; Sayeed VA
    Int J Pharm; 2010 Oct; 398(1-2):9-13. PubMed ID: 20656000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a new test for the easy characterization of the adhesion at the interface of bilayer tablets: proof-of-concept study by experimental design.
    Busignies V; Mazel V; Diarra H; Tchoreloff P
    Int J Pharm; 2014 Dec; 477(1-2):476-84. PubMed ID: 25445527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of Quality by Design (QbD) for development of bilayer tablets.
    Simão J; Chaudhary SA; Ribeiro AJ
    Eur J Pharm Sci; 2023 May; 184():106412. PubMed ID: 36828037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of compaction properties and interfacial topography on the performance of bilayer tablets.
    Kottala N; Abebe A; Sprockel O; Akseli I; Nikfar F; Cuitiño AM
    Int J Pharm; 2012 Oct; 436(1-2):171-8. PubMed ID: 22728259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of breaking tests for the characterization of the interfacial strength of bilayer tablets.
    Castrati L; Mazel V; Busignies V; Diarra H; Rossi A; Colombo P; Tchoreloff P
    Int J Pharm; 2016 Nov; 513(1-2):709-716. PubMed ID: 27717917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the Curvature of the Punches on the Shape of the Interface and the Delamination Tendency of Bilayer Tablets.
    Castrati L; Mazel V; Diarra H; Busignies V; Tchoreloff P
    J Pharm Sci; 2017 May; 106(5):1331-1338. PubMed ID: 28137698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of manufacturing process parameters causing multilayer tablets delamination.
    Bellini M; Walther M; Bodmeier R
    Int J Pharm; 2019 Oct; 570():118607. PubMed ID: 31421200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the digital revolution on the future of pharmaceutical formulation science.
    Leuenberger H; Leuenberger MN
    Eur J Pharm Sci; 2016 May; 87():100-11. PubMed ID: 26876764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tensile and shear methods for measuring strength of bilayer tablets.
    Chang SY; Li JX; Sun CC
    Int J Pharm; 2017 May; 523(1):121-126. PubMed ID: 28284920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lubrication in tablet formulations.
    Wang J; Wen H; Desai D
    Eur J Pharm Biopharm; 2010 May; 75(1):1-15. PubMed ID: 20096779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation.
    Sauzet C; Claeys-Bruno M; Nicolas M; Kister J; Piccerelle P; Prinderre P
    Int J Pharm; 2009 Aug; 378(1-2):23-9. PubMed ID: 19465095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of capping risk in pharmaceutical compacts.
    Xu X; Vallabh CKP; Hoag SW; Dave VS; Cetinkaya C
    Int J Pharm; 2018 Dec; 553(1-2):338-348. PubMed ID: 30367987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass-customization of oral tablets via the combination of 3D printing and injection molding.
    Fuenmayor E; O'Donnell C; Gately N; Doran P; Devine DM; Lyons JG; McConville C; Major I
    Int J Pharm; 2019 Oct; 569():118611. PubMed ID: 31415874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. System-wide hybrid MPC-PID control of a continuous pharmaceutical tablet manufacturing process via direct compaction.
    Singh R; Ierapetritou M; Ramachandran R
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1164-82. PubMed ID: 23523542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive and rapid analysis for observation of internal structure of press-coated tablet using X-ray computed tomography.
    Tokudome Y; Ohshima H; Otsuka M
    Drug Dev Ind Pharm; 2009 Jun; 35(6):678-82. PubMed ID: 19274513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the performance characteristics of bilayer tablets: Part I. Impact of material properties and process parameters on the strength of bilayer tablets.
    Kottala N; Abebe A; Sprockel O; Bergum J; Nikfar F; Cuitiño AM
    AAPS PharmSciTech; 2012 Dec; 13(4):1236-42. PubMed ID: 22976242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of critical factors affecting mechanical characteristics of press-coated tablets using a compaction simulator.
    Nguyen TT; Park HR; Cho CH; Hwang KM; Park ES
    Int J Pharm; 2020 May; 582():119308. PubMed ID: 32272166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.